Clearside Biomedical Inc.

10/09/2024 | Press release | Distributed by Public on 10/09/2024 04:48

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes